Semaglutida en claudicación intermitente.

Semaglutida en claudicación intermitente.

From Angio Podcast by Rodrigo Garza Herrera

January 16, 2026 · 24 min

About this episode

The episode discusses the use of GLP-1 agonists in vascular health, focusing on semaglutide and its implications for diabetes and obesity management.

Invitada: Dra. Ana Rosa Escobedo Ortiz Especialista en Endocrinología. Centro Multidisciplinario Healthy Steps. Morelia, Michoacán. Anfitrión: Dr. Rodrigo Garza Herrera Analizamos el uso de los agonistas GLP - 1, su papel en el territorio vascular, actualización en guías de diabetes y obesidad. Lectura recomendada: Estudio STRIDE doi: 10.1016/S0140-6736(25)00509-4.

People in this episode

Host: Dr. Rodrigo Garza Herrera

Guest: Dra. Ana Rosa Escobedo Ortiz

Topics covered

  • semaglutide
  • intermittent claudication
  • GLP-1 agonists
  • vascular health
  • diabetes guidelines
  • obesity

Keywords

  • semaglutide
  • claudication
  • GLP-1
  • diabetes
  • obesity
  • vascular health
  • endocrinology
  • Healthy Steps
  • Michoacán
  • STRIDE study

Mentioned in this episode

Organizations: Centro Multidisciplinario Healthy Steps

Places: Morelia, Michoacán

More episodes of Angio Podcast

Explore listener stats, chart rankings, contacts and more on the Angio Podcast podcast page.